Hydrophobicity of protein determinants influences the recognition of substrates by EDEM1 and EDEM2 in human cells by Sokołowska, Iwona et al.
Sokołowska et al. BMC Cell Biology  (2015) 16:1 
DOI 10.1186/s12860-015-0047-7RESEARCH ARTICLE Open AccessHydrophobicity of protein determinants
influences the recognition of substrates by
EDEM1 and EDEM2 in human cells
Iwona Sokołowska1, Ewa S Piłka2, Kirsten Sandvig3, Grzegorz Węgrzyn1 and Monika Słomińska-Wojewódzka1*Abstract
Background: EDEM1 and EDEM2 are crucial regulators of the endoplasmic reticulum (ER)-associated degradation
(ERAD) that extracts misfolded glycoproteins from the calnexin chaperone system. The degradation of ERAD
substrates involves mannose trimming of N-linked glycans; however the precise mechanism of substrate recognition
and sorting to the ERAD pathway is still poorly understood. It has previously been demonstrated that EDEM1 and
EDEM2 binding does not require the trimming of substrate glycans or even ERAD substrate glycosylation, thus
suggesting that both chaperones probably recognize misfolded regions of aberrant proteins.
Results: In this work, we focused on the substrate recognition by EDEM1 and EDEM2, asking whether
hydrophobicity of protein determinants might be important for these interactions in human cells. In the study
we used ricin, a protein toxin that utilizes the ERAD pathway in its retrotranslocation from the ER to the cytosol,
and a model misfolded protein, the pancreatic isoform of human β-secretase, BACE457. Mutations in the hydrophobic
regions of these proteins allowed us to obtain mutated forms with increased and decreased hydrophobicity.
Conclusions: Our data provide the first evidence that recognition of ERAD substrates by EDEM1 and EDEM2 might be
determined by a sufficiently high hydrophobicity of protein determinants. Moreover, EDEM proteins can bind
hydrophobic transmembrane regions of misfolded ERAD substrates. These data contribute to the general
understanding of the regulation of ERAD in mammalian cells.
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The endoplasmic reticulum (ER) plays a major role in
the synthesis and folding of proteins. Among them, there
are proteins operating at the plasma membrane or in the
intracellular compartments, such as the ER, the endo-
somes, the lysosomes and the Golgi apparatus [1]. Acqui-
sition of the protein’s native structure may fail or may
progress unacceptably slowly, thus the ER is equipped
with a quality control mechanism that discriminates cor-
rectly folded proteins from misfolded polypeptides [2]. As
nascent proteins emerge from the ER translocation chan-
nel, the N-glycan Glc3Man9GlcNAc2 is attached to Asn
residues. Following trimming by glucosidases I and II,
monoglucosylated N-glycans can associate with the lectin-* Correspondence: monika.slominska@biol.ug.edu.pl
1Department of Molecular Biology, University of Gdańsk, Wita Stwosza 59,
80-308, Gdańsk, Poland
Full list of author information is available at the end of the article
© 2015 Sokołowska et al.; licensee Biomed Ce
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.chaperones calnexin and calreticulin which assist protein
folding [3,4]. The entry of proteins into the monoglucose
cycle is regulated by removal and readdition of the final
glucose by glucosidase II and UDP-glucose:glycoprotein
glucosyl transferase, respectively. Properly folded proteins
leave the ER along the secretory pathway [3,4]. Irre-
versibly misfolded proteins are sorted and degraded to
neutralize their potential toxicity. This pathway is termed
ER-associated degradation (ERAD) and is triggered by ER
stress [5,6]. It results in retrotranslocation of misfolded
proteins into the cytosol, followed by polyubiquityla-
tion and proteasomal degradation. Three ER degradation-
enhancing α-mannosidase I-like proteins (EDEM1, EDEM2,
EDEM3) have been implicated in disposal of misfolded gly-
coproteins from the ER [7]. They belong to the glycoside
hydrolase 47 family (GH47) comprising also the ER α1,2
mannosidase I and the Golgi α1,2 mannosidases. EDEMs
are thought to function as lectins. It has been demonstratedntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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EDEM2 [11,12] accelerates release of terminally misfolded
glycoproteins from the calnexin chaperone system thereby
enhancing ERAD by terminating glycoprotein’s folding at-
tempts. Moreover, it is believed that in the mammalian ER,
removal of several mannose residues is necessary to elicit
disposal from the ER of misfolded glycoproteins. In this case
Man7-5GlcNAc2 glycan forms are generated [13]. There is
an ongoing debate whether the EDEM proteins are active
mannosidases. Certainly, they possess the evolutionary con-
served structure of the catalytic site as well as all the cata-
lytic residues present in the other mannosidases of the
GH47 family [14,15]. It has been demonstrated that EDEM1
can remove mannose residues from branch C [16] and as
suggested also from branch A of glycoproteins [17]. EDEM3
can also enhance de-mannosylation of ERAD substrates
[18]. Moreover, it has recently been demonstrated that
EDEM2 initiates mammalian glycoprotein ERAD by catalyz-
ing the first mannose trimming step and then mannose
trimming from Man8GlcNAc2 to Man7GlcNAc2 is per-
formed by EDEM3 and to a lesser extent also by EDEM1
[19]. Except glycan recognition, it has been shown that
EDEM1 and EDEM2 can recognize protein substrates also
in a glycan-independent manner [20-24]. Additionally, inter-
actions of both lectins with proteins may depend on the
structure of the substrate [23,24]. This was demonstrated
during studies of the protein toxin ricin and the mechanisms
of its retrotranslocation from the ER to the cytosol [23,24].
Ricin is a natural, extremely potent protein toxin iso-
lated from castor beans, the seeds of the castor plant,
Ricinus communis. Ricin holotoxin is a heterodimeric
protein that consists of two polypeptide chains (A and
B) joined by a disulfide bond [25]. The A-chain (RTA)
inhibits protein synthesis by irreversibly inactivating
eukaryotic ribosomes (for review see e.g., [26,27]). The
B-chain (RTB) is a lectin, which binds to β-1,4-linked
galactose residues. After binding to the cell surface, ricin
is endocytosed and then transported retrogradely through
the Golgi to the ER (for review see e.g. [28]). In the ER,
the disulfide bond connecting the ricin A-chain and the
B-chain is reduced [29], followed by a partial unfolding of
RTA, rendering it competent to cross the ER membrane.
Ricin A-chain is transported to the cytosol presumably
via the Sec61p translocon in a similar manner as misfolded
ER proteins [22,30]. Interaction between ricin and Sec61α
protein, the main component of the Sec61p ER transloca-
tion channel was demonstrated by co-immunoprecipitation
studies [22,30] and found in studies with isolated yeast ER-
derived microsomes [31]. It was reported that retrograde
translocation of ricin A-chain was dependent on a func-
tional Sec61p complex [31]. Despite the fact that ricin is not
a typical ERAD substrate it can utilize specific components
of ER quality control to be translocated to the cytosol. In
addition to interaction with EDEM1 [22,23] and EDEM2[24], ricin A-chain requires SEL1L, a component of the
mammalian HRD1 E3 ubiquitin ligase complex that takes
part in the recognition of ER degradation substrates [32-34].
Interestingly, it has recently been demonstrated that in con-
trast to Shiga toxin, chaperone protein BiP (Grp78) nega-
tively regulates ricin A-chain translocation from the ER to
the cytosol [35]. Ricin A-chain contains a 12-amino-acid
hydrophobic region (Val245 to Val256), which is located
close to its C-terminus. This region is hidden in the holo-
toxin but becomes exposed upon A and B chain dissociation
in the ER. It is possible that exposure of the RTA hydropho-
bic region in the ER triggers an interaction between
ricin A-chain and membranes, ER chaperones or even
ER translocons. It has been demonstrated that substi-
tution of proline 250 into alanine (P250A) in this region
results in a dramatic decrease in RTAP250A cytotoxicity in
Vero and HEK293 (human embryonic kidney) cells
[23,36]. Decreased cytotoxicity of P250A ricin was ex-
plained by increased endosomal-lysosomal degradation
of the toxin as well as reduced transport from the ER
to the cytosol [23]. Moreover, transport of modified
RTA to the cytosol, in contrast to wild-type RTA, ap-
peared to be EDEM1- and EDEM2- independent [23,24].
The introduced P250A mutation alters the secondary
structure of RTA into a more helical structure suggesting
that EDEMs recognition might be determined by the
structure of the ERAD substrate. Recognition of protein
substrates by ER chaperones remains poorly defined. In
the case of EDEM proteins it has been suggested that be-
sides glycans, EDEM1 can recognize misfolded regions of
aberrant proteins [19] such as exposed hydrophobic do-
mains [10,37]. In this study, we have verified that changed
hydrophobicity of protein determinants may influence
protein substrate interaction with EDEM1 and EDEM2.
We have demonstrated that ricin A-chain and a model
misfolded protein, BACE457 carrying mutations that
significantly decreased their hydrophobicity, are poorly
recognized by EDEM1 and EDEM2 in contrast to their
wild-type counterparts. Moreover, degradation of mu-
tated BACE457 with decreased hydrophobicity is signifi-
cantly reduced. Thus, we conclude that the chaperone
proteins EDEM1 and EDEM2, similarly to the so called
‘classical chaperones’, recognize hydrophobic regions of
the protein substrates and interact with determinants that
posses relatively high degree of hydrophobicity.
Results
Biophysical characteristics of RTA mutants
To elucidate the significance of changed hydrophobicity
of ricin A-chain on its intracellular transport and inter-
action with EDEM1 and EDEM2 proteins, we cloned ap-
propriate genes with certain mutations and purified
mutated forms of RTA containing amino acid substitu-
tions in the C-terminal hydrophobic region of the ricin
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is important in ricin cytotoxicity [23,36]. The purpose of
the mutagenesis was to change the hydrophobicity of the
desired region but to retain the secondary structure and
mostly unaltered tertiary structure of the ricin A-chain.
Detailed analysis based on the crystal structure of RTA
[38] allowed us to select particular amino acids to be
substituted (Table 1). This analysis showed that in the
highly hydrophobic C-terminal region of ricin A-chain
four residues can be substituted into hydrophilic residues
without affecting RTA structure and its interaction with
ricin B-chain (Table 1). Kyte-Doolittle hydropathy analysis
revealed significant decrease in the hydrophobicity of this
region (Figure 1A, B). On the other hand, two residues
present in this region can be substituted into more
hydrophobic residues increasing overall hydrophobicity
of this region (Table 1, Figure 1A, B). Based on this in-
formation, we produced ricin A-chain with decreased
hydrophobicity in the C-terminal region (referred as
RTADHF, see Methods) (Figure 1A, B) containing V245S,
L248N, I252N, A253S substitutions. Similarly, the two
substitutions (S246V, A253V) were introduced by site-
directed mutagenesis to produce ricin A-chain with in-
creased hydrophobicity in the C-terminal region (referred
as RTAIHF, see Methods) (Figure 1A, B). Secondary struc-
tures of RTADHF and RTAIHF were examined by circular
dichroism (CD) and compared with the spectrum forTable 1 Mutational analysis of the C-terminal hydrophobic re
RTA decreased hydrophobicity
Position in RTA,
C-terminal region
Primary residue Altered resid
Uncharged
245 Val (V) Ser (S)
247 Ile (I) Asn (N)
248 Leu (L) Asn (N)
249 Ile (I) Asn (N)
250 Pro (P) Ala (A)
251 Ile (I) Asn (N)
252 Ile (I) Asn (N)
253 Ala (A) Ser (S)
254 Leu (L) Asn (N)
255 Met (M) Gln (Q)
256 Val (V) Ser (S)
RTA increased hydrophobicity
Position in RTA, C-terminal region Primary residue Altered resid
Uncharged
246 Ser (S) Val (V)
253 Ala (A) Val (V)
Mutations that were chosen to be introduced into this region are marked in bold.unmodified RTA. Spectra for both RTA mutants indicate
no significant alternations in their secondary structure
(Figure 1C). The predicted models of RTADHF and
RTAIHF designed by Geno3D Server [39] did not show
any significant changes in their tertiary structure when
compared to the model of wild-type ricin A-chain (see
Additional file 1A, B), what confirms our previous in
silico analysis. Additionally, there are no alternations
in the localization of the mutated hydrophobic regions
of ricin A-chain within the protein (see Additional file
1A, B) and there are no significant changes in the sur-
face charge distribution between wild-type RTA and
mutated forms, DHF and IHF (see Additional file 1C).
To characterize the correct folding and overall stability of
RTADHF and RTAIHF, their sensitivity to trypsin (Figure 2A)
and pronase (see Additional file 2) was compared to that of
wild-type RTA. Digestion patterns for the ricin A-chain
mutants and wild-type counterpart were the same, con-
firming equal in vitro stability of mutant RTADHF, RTAIHF
and the wild-type protein (Figure 2A, see Additional file 2).
The digestion patterns significantly differ for denatured
forms of ricin A-chain (Figure 2A, see Additional file 2)
what further confirms high stability of native forms of RTA.
The obtained modified ricin A-chain proteins were
reassociated with ricin B-chain to form a holotoxin
(RTADHF:RTB, RTAIHF:RTB; see Methods). To ensure
that the introduced mutations were not affecting thegion (Val245 to Val256) of ricin A-chain
ue Comments
Charged
- Suggested
Asp (D) Not recommended, might disrupt RTA fold
Asp (D) Asp may change RTA interactions, Asn suggested
Asp (D) Not recommended, might disrupt fold and affect
interaction with B-chain
- Not recommended, Ala changes the structure of RTA [23]
Asp (D) Not recommended, affects interaction with B-chain
Asp (D) Asp may change RTA interactions, Asn suggested
- Suggested
Asp (D) Not recommended, might disrupt RTA fold
Lys (L) Not recommended, might disrupt RTA fold
- Not recommended, might disrupt RTA fold
ue Comments
Charged
- Suggested
- Suggested
Figure 1 Biochemical characteristics of RTADHF and RTAIHF. (A) Sequence of the C-terminal hydrophobic region of ricin A-chain. Introduced
mutations are marked in red. (B) Hydrophobicity plot for the C-terminal region (Val245-Val256) of wild-type ricin A-chain, wt, DHF ricin A-chain
and IHF ricin A-chain. Presented graphs are fragments of the output from ProtScale [64] prepared for full-length ricin A-chains. A sliding window
of 13 AAs was used. Wild-type RTA (unbroken line); RTADHF (dashed line); RTAIHF (dotted line) (C) Far UV CD spectra of wild-type RTA, wt; RTADHF
and RTAIHF. The scans were corrected by the subtraction of blanks containing only the buffer. Averaged spectra from three measurements;
s.d. ≤ 3%. Wild-type RTA (unbroken line); RTADHF (dashed line); RTAIHF (dotted line).
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decreasing the possibility of reductive cleavage, mutant
RTADHF, RTAIHF and wild-type holotoxin were incu-
bated with increasing amounts of dithiothreitol (DTT).
The results showed no significant difference in the
RTA mutants reducibility in comparison to wild-type
holotoxin (Figure 2B). The denatured forms of ricin
were reduced by much lower concentrations of redu-
cing agent (Figure 2B), what also indicate that native
forms of ricin holotoxin, wild-type and mutant forms
DHF and IHF are properly folded.
The ricin A-chain mutants are not toxic to HEK293 cells
To investigate whether mutations in the hydrophobic re-
gion of RTA influence modified ricin A-chain cytotoxicity,
HEK293 cells were incubated with increasing concentra-
tions of wild-type or mutated forms (DHF, IHF) of ricin
for 3 hours and the protein synthesis was then measured.
Data show that the introduced mutations that changed
hydrophobicity of the C-terminal region of RTA, com-
pletely abolished the cytotoxicity of ricin (Figure 3). To
further explain this observation, we compared the intra-
cellular amount of ricin DHF, ricin IHF and wild-type
ricin. Cells were incubated with wild-type holotoxin or
mutants with changed hydrophobicity for 3 hours. Then
intact toxin was immunoprecipitated from the cell lysates,
separated under non-reducing conditions and analyzed
with anti-RTA antibodies. The results showed significant
decrease in the amount of both ricin DHF and ricin IHF
compared to the amount of wild-type toxin present in the
cells (Figure 4A).Mutations that change hydrophobicity of RTA
influence the binding of modified proteins to the cell
surface as well as affect their endosomal-lysosomal
degradation
Abolished cytotoxicity of ricin DHF and ricin IHF is at
least partially connected with a decreased intracellular
level of both proteins. To further investigate the reason
for the reduced amounts of both mutated forms of ricin,
measurement of binding of ricin holotoxin DHF and
IHF to the cell surface was performed. Cells were incu-
bated with ricin at 0°C. This temperature stabilizes ricin
bound the cell surface [40]. In this experiment Western
blot analysis with anti-RTA antibodies was applied
(Figure 4B). In the case of both mutated forms of ricin
(DHF and IHF), there was a significant decrease in the
amount of cell surface-bound holotoxin proteins with
changed hydrophobicity in comparison to the wild-
type protein (Figure 4B). Observed differences were
not due to the decreased stability of ricin DHF and
ricin IHF after incubation on ice, as presented in Figure 4C.
These data suggest surprisingly that introduced mutations
in the hydrophobic region of RTA affect the binding of
ricin IHF and ricin DHF to the cell surface. This may ex-
plain decreased intracellular levels of both forms of ricin
(Figure 4A). There are not any published results describing
the importance of RTA in the ricin holotoxin recognition
and binding to the cell surface receptors. We can assume
that interaction of modified ricin A-chains with the
B-chain in the holotoxin is somehow altered, what
might influence recognition of cell surface receptors
by RTB (see Discussion).
Figure 2 Stability and reduction possibilities of DHF ricin and IHF ricin. (A) Coomasie Blue-stained 12% SDS/PAGE gels showing the effect
of the incubation of 500 ng of wild-type ricin A-chain, RTA wt, and modified ricin A-chains: RTADHF and RTAIHF, with increasing concentrations of
trypsin. Digestion patterns for denatured forms of RTA are also shown. (B) Coomasie Blue-stained 12% SDS/PAGE gels showing the effect of increasing
concentrations of dithriothreitol (DTT) on the reduction of native and denatured forms of wild-type holotoxin, DHF holotoxin and IHF holotoxin.
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and DHF ricin might also result from the increased
endosomal-lysosomal degradation of both mutated forms
of ricin, the total amounts of wild-type, IHF ricin and
DHF ricin were estimated by Western blot analysis in cells
cultured with and without bafilomycin A1. Bafilomycin
A1 is an inhibitor of the vacuolar H+-ATPase [41]. As
shown in Figure 4D, bafilomycin A1 only slightly increases
the intracellular amount of wild-type ricin but significantly
elevates the amounts of the mutated forms of ricin. Im-
portantly, the increase in the amounts of IHF ricin and
DHF ricin in the presence of bafilomycin A1 is higher
than for wild-type ricin when compared to their counter-
parts not treated with this inhibitor (Figure 4D). There-
fore, both forms of ricin with increased and decreased
hydrophobicity in the C-terminal region are more effect-
ively degraded in low-pH compartments in comparison to
the wild-type protein. Interestingly, bafilomycin A1 in-
creases also the amounts of partly degraded forms of IHFholotoxin and DHF holotoxin. All this may explain de-
creased intracellular amount of ricin mutants.
It has been demonstrated that ricin carrying a point
mutation in the hydrophobic region of RTA (P250A) is
subjected to increased endosomal-lysosomal degradation
and that mainly cathepsin B but also cathepsin D are re-
sponsible for the degradation of the ricin holotoxin
P250A mutant in the cell [23]. In our next experiments
we used pepstatin A, which is a potent inhibitor of
aspartyl proteases, including cathepsin D, and CA074
methyl ester that blocks cysteine cathepsins, especially
cathepsin B. We found that both cathepsins are also in-
volved in the degradation of ricin IHF and ricin DHF
(see Additional file 3).
RTA mutants with changed hydrophobicity are
transported to the Golgi apparatus and to the ER
To elucidate if IHF ricin and DHF ricin, similarly to the
wild-type toxin, are transported to the Golgi apparatus,
Figure 3 DHF ricin and IHF ricin are not toxic to HEK293 cells.
Effect of increasing concentrations of DHF ricin, IHF ricin and wild-type
ricin on HEK293 cells. Wild-type ricin, wt, (closed circles); modified ricin:
DHF, (closed squares), IHF, (open squares). Data with s.d. from five
independent experiments.
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sulfated in the Golgi complex were examined. For this
purpose wild-type ricin sulf-1 as well as the mutants
IHF ricin sulf-1 and DHF ricin sulf-1, modified ricin
molecules containing a sulfation site in the A-chain,
were used. When cells are incubated with 35SO4
2−,
the A-chain becomes radioactively labeled due to the
sulfotransferase in the trans-Golgi cisternae [42], and
the fate of the 35SO4
2−-labeled ricin molecule can be
studied. As shown in Figure 4E, sulfated IHF ricin
holotoxin and DHF ricin holotoxin can be detected
after 3 hours incubation with the toxin. Thus, despite
a dramatic reduction in the amount of both types of
ricin in the cell, small fractions are transported to the
Golgi apparatus. This experiment also shows a detect-
able fraction of a sulfated RTADHF and RTAIHF. Since
SDS-PAGE was performed under non-reducing condi-
tions, it means that small amounts of mutated IHF
holotoxin and DHF holotoxin reach the ER where
they become reduced.
Recognition of RTADHF by chaperone proteins EDEM1 and
EDEM2 is significantly decreased
It was shown previously that EDEM1 and EDEM2
proteins interact directly with the ricin A-chain
[22-24]. The point mutation in the hydrophobic re-
gion of RTA (P250A) impairs interactions between
EDEM1 and RTA [23] and between EDEM2 and RTA
[24]. Since P250A mutation changes the conformation
of the ricin A-chain into a more helical structure, it
was concluded that the precise structure of RTA
might determine its recognition by EDEM1 and
EDEM2 [23,24]. To further investigate the mechanism
of substrate recognition by EDEM1 and EDEM2,
interaction of EDEM proteins with RTAIHF and
RTADHF was examined. We cloned and purified the
RTA mutants with His-tag (see Methods) that werenext used in the pull-down assays. In these experi-
ments equal amounts of mutated forms of RTA and
wild-type RTA were used. Figure 5 shows a significant
decrease in RTADHF binding to EDEM1 and EDEM2
when compared to the wild-type RTA. Interactions be-
tween RTAIHF and EDEM1 and between RTAIHF and
EDEM2 showed no statistically significant (p > 0.05)
differences in comparison to interactions with wild-
type RTA (Figure 5). These results indicate that for
interactions between both EDEM1 and RTA and
EDEM2 and RTA appropriate hydrophobicity of the
substrate is important. In conclusion, reduced hydro-
phobicity of the C-terminal region of RTA results
in impaired interactions with EDEMs chaperone
proteins.
Recognition of the C-terminal region of BACE457 by
EDEM1 and EDEM2 depends on the hydrophobicity of
this region
To investigate whether the effect of the hydrophobicity
is also important in interactions between EDEMs and a
typical ERAD substrate, we used the model misfolded
protein, BACE457. This protein is a spice variant of hu-
man brain isoform BACE501, β-site amyloid precursor
protein cleaving enzyme, which is a type I transmem-
brane aspartyl protease. BACE457 is expressed in human
pancreas, its gene lacks 132 base pairs, what causes an
in-frame deletion of 44 amino acids in the full-length
BACE501 [43]. It has been demonstrated that overex-
pression of EDEM1 accelerates degradation of BACE457
but has no effect on properly folded BACE501 [10].
Both forms of BACE have a hydrophobic region on
their C-terminal end (in BACE457, Ile414-Val434) that
serves as a transmembrane domain. It remains unclear
how misfolded membrane proteins are selected and
destroyed during ERAD, however, except mannose trim-
ming from N-linked oligosaccharides, recently published
results presented a possible role for the transmembrane
regions in this process [44-46] (see also Discussion).
To elucidate whether changed hydrophobicity of the
C-terminal region of BACE457 would affect its interac-
tions with EDEM1 and EDEM2 proteins, we cloned a
mutated form of BACE457 (BACE457DHF), carrying three
substitutions (V417G, L424G, L427G) (Figure 6A) that ef-
ficiently decrease hydrophobicity of the C-terminal region
of this protein (Figure 6B). To minimalize the possibility
of the disruption of the specific structure of this misfolded
protein, we avoid any modifications of cysteine residues
and did not modify any residues neighboring cysteines.
In silico predictions revealed that these mutations did
not change hydrophobicity to such an extent that
it disturbs transmembrane location of this region
(Figure 6C) or that it changes misfolding status (e.g.
into more unfolded state) of the luminal part of
Figure 4 (See legend on next page.)
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Figure 4 DHF ricin and IHF ricin show decreased binding to the cell surface and increased degradation in low pH vesicles. (A) HEK293
cells after 3 hours incubation with wild-type ricin, IHF ricin or DHF ricin run on SDS/PAGE under non-reducing conditions. A representative membranes
after Western blot with anti-RTA antibodies are shown. Western blots with anti-tubulin antibodies were performed to show equal loading control. Data from
three independent experiments are presented. RTA wt is marked as 1, other results are relative to this control. (B) Cells were incubated with wild-type ricin,
IHF ricin or DHF ricin for 30 min at 0°C. Binding was measured as described in Methods. A representative membranes after Western blot with anti-RTA
antibodies are shown. Western blots with anti-tubulin antibodies were performed to show equal loading control. Data from three independent
experiments are presented. RTA wt is marked as 1, other results are relative to this control. (C) Coomasie Blue-stained 12% SDS/PAGE gels showing the
stability of 500 ng of wild-type ricin, and modified ricin IHF and DHF after 30 min incubation at 0°C. (D) Cells were treated with or without bafilomycin
A1 (0.1 μM) and with wild-type ricin, IHF ricin or DHF ricin. The amounts of ricin that remain in the cell after degradation was analyzed after SDS-PAGE
run under non-reducing conditions (see Methods). Representative membranes after Western blot with anti-RTA antibodies are shown. Western blots
with anti-tubulin antibodies were performed to show equal loading control. Data from three independent experiments are presented. Ricin wt, ricin
IHF and ricin DHF in each graph are marked as 1, other results are relative to this control. All degraded forms of ricin were analyzed. (E) Tyrosine
sulfated wild-type ricin sulf-1, and modified ricin sulf-1: IHF or DHF in cells after 3 hours incubation with Na2
35SO4 and further 3 h incubation
with the toxins, run on SDS/PAGE under non-reducing conditions. Control experiments revealed equal total sulfation of proteins in cell lysates.
A representative autoradiogram is shown.
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changes might influence ERAD [44-46] and affect in-
teractions between BACE457 and EDEM proteins
beyond the studied decreased hydropobicity of the C-
terminal region of BACE457. Importantly, experimen-
tal data presented in Figure 7 confirms transmembrane
localisation of modified BACE457DHF. Cells were
permeabilized with a various concentrations (0–
100 μg/ml) of a nonionic detergent, digitonin to separ-
ate cytosolic fraction form the membranes. LowerFigure 5 Mutations that change hydrophobicity of the C-terminal regio
(A) His-tag pull-down assay with RTA-His, RTADHF-His and RTAIHF-His (0.5 μg e
or cells transfected with an control vector, Ctrl. Proteins bound to the Ni-NTA
antibodies (upper panel). The same membranes were re-probed with an
with anti-HA antibodies are shown in the bottom panel. A representativ
with s.d. from four independent experiments. The amount of EDEM1 b
interacting with wild-type RTA which is marked as 1. Data were analyz
His-tag pull-down with s.d. from four independent experiments. The a
amount of EDEM2 interacting with wild-type RTA which is marked as 1concentrations of digitonin, up to 5 μg/ml, selectively
permeabilise plasma membrane, remaining ER mem-
brane intact [22,23], higher concentrations of this de-
tergent permeabilise also ER membrane causing
leakage of soluble ER proteins to the cytosol, at a very
high concentrations of digitonin the integrity of the ER
membrane may be disturbed. Control experiments per-
formed with a ER membrane protein, calnexin and a
luminal protein calreticulin revealed stable transmem-
brane location of calnexin (Figure 7A). Calreticulin wasn of ricin A-chain influence its interaction with EDEM1 and EDEM2.
ach) and lysates from HEK293 cells overexpressing EDEM1-HA, EDEM2-HA
beads were analyzed by SDS/PAGE and Western blot with anti-HA
ti-RTA antibodies (middle panel). Whole cell lysates (WCL) analyzed
e experiment is shown. (B) Average data from His-tag pull-down
ound to RTADHF or RTAIHF is relative to the amount of EDEM1
ed by Student’s t-test , *P < 0.001, •P = 0.112 (C) Average data from
mount of EDEM2 bound to RTADHF or RTAIHF is relative to the
. Data were analyzed by Student’s t-test, *P < 0.001, •P = 0.155.
Figure 6 Biochemical characteristics of BACE457DHF. (A) Sequence of the C-terminal hydrophobic region of BACE457. Introduced mutations
are marked in red. (B) Hydrophobicity plot for the C-terminal region (Ile414-Val434) of BACE457 and BACE457DHF. Presented graph is a fragment
of the output from ProtScale [64] prepared for full-length BACE457. A sliding window of 19 AAs was used. (C) Topology prediction of BACE457
and BACE457DHF prepared by TMHMM Server v. 2.0 [66]. Graph shows the posterior probabilities of inside/outside/transmembrane helices. The red
bars indicate predicted transmembrane regions, their length and posterior probabilities are indicated on X and Y axes respectively.
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brane remained intact, at higher concentrations of digito-
nin, calreticulin was released to the cytosolic fraction
(Figure 7A). Stable location of BACE457DHF in the mem-
brane fraction, similarly to BACE457, confirms ER mem-
brane localization of BACE457DHF (Figure 7B). In contrary
to these observations, soluble form of BACE457 –
BACE457Δ [47] was released to the cytosolic fraction at
relatively low concentrations of digitonin (Figure 7B). To
further confirm this observation, we investigated by confocal
microscopy the localisation of BACE457, BACE457DHF and
BACE457Δ together with calnexin. Cells were permeabilised
with 60 μg/ml of digitonin. Due to the Western blot analysis
presented in Figures 7A, B such concentration of detergent
leaves the ER membrane proteins in the membrane fraction
and almost completely clears this fraction form the solubleER proteins. BACE457 and BACE457DHF were detected in
the membrane fraction and both proteins were found to co-
localise with calnexin (Figure 7C). BACE457Δ was not de-
tected in this fraction what confirms our previous
observations.
To study interactions between BACE457DHF and EDEM1
and between BACE457DHF and EDEM2, we coimmuno-
precipitated BACE457DHF and in control experiments
BACE457 with anti-HA antibodies from lysates of EDEM1-
HA or EDEM2-HA-transfected cells (see Methods). As
shown in Figure 8 BACE457 interacts with both EDEM1
and EDEM2. However, interactions of both chaperone
proteins with BACE457DHF are significantly reduced
(Figure 8). It means that mutations responsible for de-
creased hydrophobicity of the C-terminal region of
BACE457 influence its recognition by the chaperone
Figure 7 BACE457DHF is a membrane protein. (A) Cells were subjected to permeabilisation (see Methods) with increasing concentrations of
digitonin, concentrations as indicated. A representative membranes of cytosolic fraction and membrane fraction after Western blot with anti-calnexin
(clx) or anti-calreticulin (cln) antibodies are shown. (B) Cells were transfected with cDNA encoding BACE457, BACE457DHF or BACE457Δ and subjected
to permeabilisation with increasing concentrations of digitonin, concentrations as indicated. A representative membranes of cytosolic fraction and
membrane fraction after Western blot with anti-BACE antibodies are shown. (C) Cells were transfected with cDNA encoding BACE457, BACE457DHF or
BACE457Δ and subjected to permeabilisation with 60 μg/ml of digitonin. Then cells were fixed and stained as indicated in Methods. Bars, 10 μm.
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EDEM proteins alone or as a part of larger complexes
are able to recognize hydrophobic transmembrane do-
mains of misfolded ERAD substrates. Additionally, it
seems that sufficiently high hydrophobicity of proteinsubstrate determinants is important for interactions
with EDEM1 and EDEM2.
It is believed that EDEM1 and EDEM2 are crucial ER
chaperons involved in ERAD disposition of aberrant gly-
coproteins [9-12]. To examine the degradation rate of
Figure 8 Decreased hydrophobicity of BACE457 impairs its interactions with EDEM1 and EDEM2. Co-immunoprecipitation of BACE457 or
BACE457DHF with anti-HA antibodies from cells overexpressing EDEM1-HA (A) or EDEM2-HA (B). Representative examples of the experiments are
shown. Membranes were re-probed with anti-HA antibodies to confirm equal immunoprecipitation. Whole cell lysates (WCL) analysed with
anti-BACE antibodies are shown in the bottom panel. (C), (D) Graphs of the average data presented in (A) and (B) with s.d. from three independent
experiments are shown. The level of immunoprecipitated BACE457 from EDEM1-transfected cells or EDEM2- transfected cells is marked as 1, the level of
immunoprecipitated BACE457 DHF is relative to this value.
Figure 9 Degradation of BACE457DHF is completely inhibited.
(A) The amount of labeled BACE457 and BACE457DHF remaining at
the end of a chase, times as indicated. Representative examples of
the experiments are shown. (B) Kinetics of degradation were determined
by densitometric analysis of the labeled proteins. Graph of the average
data with s.d. from three independent experiments is shown.
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or BACE457 cDNAs were pulse-labeled with [35S]-Met,
chased with unlabeled media up to 6 h followed by
BACE457 immunoprecipitation from cell lysates. Deg-
radation of BACE457 was started after a lag phase of
about 90 min and then proceeded with a half-life of
3.5 hours (Figure 9). This is consistent with earlier
published results [10,47]. Interestingly, degradation of
BACE457DHF was completely inhibited (Figure 9). We
cannot exclude the possibility that high stability of
changed BACE457 is at least partially connected with
inhibited interactions with EDEM1 and EDEM2 pro-
teins, however the possibility that decreased hydropho-
bicity of the C-terminal region of BACE457 results
also in a lack of interactions with other important
ERAD regulator(s) should be taken into consideration.
Discussion
It is believed that mechanisms regulating recognition and
degradation of folding-defective polypeptides expressed in
the ER is one of the central issues determining the proper
functioning of human cells. How proteins are sorted for
ERAD is still poorly understood. Studies that have been
performed during last decade show that EDEM family
proteins are important regulators involved in disposal of
misfolded glycoproteins from the ER [8-12,16-19].
In this study, we found that hydrophobic regions of
the protein substrates seem to play a significant role in
their recognition by the chaperone proteins EDEM1 andEDEM2. Recognition of ERAD substrates and protein
toxins in the ER seems to be a complex issue. N-linked
oligosaccharides are undoubtedly used as specific signal
tags for ERAD and specific signals generated and/or rec-
ognized by EDEM proteins. EDEM proteins conserve all
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binding of the specific inhibitor of α1,2 mannosidases,
kifunensine [8,15,48]. It has been demonstrated that an
increase of the intraluminal level of EDEM1 [17] and
EDEM3 [18] substantially accelerates demannosylation
of folding-defective polypeptides. Interestingly, it has
been shown that at low EDEM1 levels its association
with the ERAD substrate is glycan dependent whereas,
at high levels it is not [49]. Glycan independent interac-
tions of EDEM1 have been shown for: NHK, mutant
variant of α1-antitrypsin (A1AT) [19], mutant P23H rod
opsin [20] and the protein toxin ricin [22,23]. In the case
of ricin, interactions with EDEM2 were also not dependent
on carbohydrates [24]. Moreover, it has recently been
shown that EDEM1 can associate with a glycoprotein sub-
strate in the absence of the mannose-trimming activity
[50]. All these observations led to the suggestion that in
addition to N-linked oligosaccharide moieties of glycopro-
teins, EDEM proteins can recognize misfolded regions of
aberrant proteins.
Ricin is not a typical ERAD substrate, however after
holotoxin reduction in the ER, ricin A-chain utilizes
ERAD and its components in its retrotranslocation to
the cytosol [22-24,30,32]. It has been demonstrated pre-
viously that a point mutation (P250A) in the hydropho-
bic region of RTA alters the secondary structure of RTA
into a more helical structure without affecting the
hydrophobicity of the C-terminal region of RTA [23].
The interactions between EDEM1 and RTAP250A [23]
and EDEM2 and RTAP250A [24] were significantly re-
duced indicating that EDEM1 and EDEM2 protein rec-
ognition might be determined by the structure of the
ERAD substrate.
In this study we have cloned genes coding for ricin A-
chain mutants with decreased (DHF) and increased
(IHF) hydrophobicity of the C-terminal region of RTA,
to further characterize the molecular basis of substrate
recognition by EDEM1 and EDEM2. Binding of both
mutated forms of ricin to the cell surface receptors was
significantly decreased. In ricin holotoxin, the B- chain
is a lectin, which binds to β-1,4-linked galactose residues
widely present on mammalian cell surface glycoproteins
and glycolipids. There is no direct contribution of ricin
A-chain to the recognition and receptor binding of the
ricin holotoxin. Re-association of RTADHF or RTAIHF
with RTB produces a holotoxin with a reducible disul-
fide bond. However, due to the significant hydrophobic
changes in the mutated RTA (that might result in induc-
tion of an atypical entropic and enthalpic penalties of
hydratation [51]), modified holotoxins can have altered
conformation in comparison to the wild-type holotoxin
e.g. changed localization of RTB in relation to RTA. This
might influence binding of mutated forms of ricin holo-
toxin to the cell surface receptors. Decreased degradationof ricin DHF and ricin IHF in the presence of inhibi-
tors of aspartyl and cysteine proteases represents the
ricin transported to endosomes and lysosomes in an
ER-independent pathway. However, we cannot exclude
the possibility that the ricin mutated forms can also be af-
fected by UPS (ubiquitin proteasome system)-mediated
degradation. Despite decreased intracellular levels of ricin
DHF and ricin IHF, both forms reached the Golgi complex
and then the ER. However, due to the small amounts of
mutated ricin A-chains present in the ER, it was impos-
sible to study their retrotranslocation to the cytosol and
examine their sensibility to proteasomal degradation, as
was done for RTAP250A [23,24]. Importantly, pull-down
experiments revealed that EDEM1 and EDEM2 recognize
ricin A-chain with decreased hydrophobicity with sig-
nificantly lower affinity. Thus, both EDEM proteins
bind exposed hydrophobic domains that possess appropri-
ate high hydrophobicity. On the other hand, increased
hydrophobicity of the C-terminal region of ricin A-chain
does not result in elevated level of binding to EDEM1
and EDEM2. We cannot however exclude the possibil-
ity that other chaperone protein(s) present in the cell
lysate bind the mutated highly hydrophobic region of
RTA so strongly that they inhibit to some extent
RTAIHF interactions with EDEM1 and EDEM2. Alter-
natively, we can speculate that in the case of RTAIHF
the increase in the hydrophobicity was not high enough
to observe increased level of binding to EDEM1 and
EDEM2.
BACE457 is relatively well characterized ERAD sub-
strate. Most of the proteins transiently expressed in human
cells undergo inefficient folding in the ER, leading to pro-
teasomal degradation. Detailed analysis revealed that
BACE457 is firstly directed to the ER folding machinery,
the calnexin cycle. After an insufficient folding process, ex-
tensively oxidized BACE457 transiently enters in
disulfide-bonded complexes associated with the luminal
chaperone BiP and protein disulfide isomerase (PDI) [47].
EDEM1 overexpression resulted in faster release of
BACE457 from the calnexin cycle and earlier onset of
its degradation, whereas EDEM1 downregulation pro-
longed its folding attempts and delayed ERAD [10].
Moreover, it has been demonstrated, that elevation of
the intralumenal concentration of EDEM1 accelerated
ERAD of BACE457 by efficient de-mannosylation of
N-linked oligosaccharides [17]. In this study, we show
that EDEM1 and EDEM2 are able to recognize the
hydrophobic region of BACE457 which may significantly
contribute to its degradation, since BACE457 with a muta-
tion that decreases hydrophobicity of this region is less
effectively recognized by EDEM1 and EDEM2, and
degradation of BACE457DHF is abolished. These results
are in agreement with data for RTADHF, confirming that
EDEM1 and EDEM2 recognize protein determinants
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tion might represent an important step in the differentiation
between proteins undergoing a folding process and termin-
ally misfolded proteins directed for degradation. The differ-
entiation might be based on more extensive exposure of
hydrophobic domains by terminally misfolded glycoproteins.
Moreover, these data contribute to our overall under-
standing of ERAD of membrane proteins. Integral mem-
brane substrates expose one or more regions to the
cytoplasm, which can be ubiquitinated. Under debate is
whether ubiquitinated membrane proteins are degraded
by the proteasome in situ at the membrane or whether
they are extracted prior to proteolysis. Alternatively,
degradation could start from an internal site on a cyto-
plasmically exposed loop after an endoproteolytic clip by
the proteasome [45]. In these models, it is assumed that
degradation and retrotranslocation are tightly coupled
and occur at the ER membrane. On the other hand, some
integral membrane ERAD substrates, such as MHCI [52]
and cystic fibrosis transmembrane conductance regulator
(CFTR) [53], have been observed to reside in the cyto-
plasm when proteasome function is compromised. These
data suggested that transmembrane hydrophobic seg-
ments might be solubilized from the lipid bilayer of
the ER prior to proteasome-mediated degradation. In-
deed, it has been demonstrated that the transmembrane
domain of the ERAD substrate, Ste6p, is released into the
cytosol in a Cdc48/p97- and ATP-dependent manner [44].
Candidates for factors that could maintain the solubility of
transmembrane domains include cytoplasmic chaperones
(such as Cdc48p), proteasome associated factors such as
Rad23p/Dsk2p [54], and the 19S particle. Interestingly,
it has been recently demonstrated that the proteasome
19S subunit can act as chaperone protein also for ricin
A-chain, preventing aggregation of unfolded RTA [55].
Moreover, it was suggested that misfolding status of
the cytoplasmatic domains of membrane ERAD sub-
strates might influence the assembly of the intramem-
brane domain, which is recognized by Hrd1p, an E3
ubiquitin ligase complex [44]. Some reports suggest
that an Hsp70 family member-containing or putative
lectin-containing complex in the ER helps to recruit a
misfolded substrate to the Hrd1p complex [56-58].
The mannosidase-like domain of EDEM1 does not appear
to be required for ERAD substrate binding, but this do-
main is involved in binding to SEL1L-containing ER mem-
brane dislocation and ubiquitination complex [19]. It is
possible that this domain also recognizes hydrophobic
patches of aberrant proteins. We cannot exclude the pos-
sibility that recognition of hydrophobic transmembrane
domains by EDEM1 and EDEM2 is necessary for
solubilization from the lipid bilayer or that EDEMs
recognize already solubilized transmembrane domains.
Importantly, it has been demonstrated that severalless-hydrophobic transmembrane sequences derived from
multimeric transmembrane protein complexes can enter
the ER lumen completely, where they are recognized as
substrates of the chaperone BiP, which in turn initiate deg-
radation of the unassembled subunit [59]. This new mech-
anism suggests a general link between proper integration
of transmembrane segments and the ER luminal chaperone
machinery. Interactions between hydrophobic transmem-
brane domain of BACE457 and EDEMs might explain dif-
ferences between ERAD of membrane BACE457 and its
luminal form BACE457Δ. Degradation of BACE457Δ is
faster than that of membrane BACE457; half-life of
BACE457Δ is about 40 min, while that of BACE457 is 4 h
[47]. Importantly, the lag phase for the soluble variant of
BACE457 is only 15 min, whereas for membrane bound
BACE457 it is 90 min [47]. These differences might be
connected with necessity of extraction of transmembrane
domain of BACE457 out of the ER membrane. Hebert and
colleagues suggested that EDEM1 serves as a quality con-
trol receptor that acts as a molecular link between mis-
folded proteins and SEL1L [19]. Recently published results
show that degradation of BACE457 did not require SEL1L
complex [60]. However, ricin A-chain transport to the
cytosol depends on SEL1L [32]. It is possible that the role
of EDEM1 and EDEM2 in ERAD in some aspects is com-
mon for luminal and membrane substrates: extraction
from the calnexin/calreticulin cycle and substrate de-
mannosylation (at least in the case of EDEM1). However,
after release from EDEM1 or/and EDEM2, terminal accep-
tors of misfolded membrane proteins might be different
from luminal aberrant glycoproteins.
About one-third of all mammalian genes encode se-
creted and membrane proteins, including numerous im-
portant molecules such as ion channels and cell surface
receptors [61]. The high rate of protein synthesis and
the large fraction of misfolded and unassembled proteins
generated in the ER, indicate that the ERAD plays a cen-
tral role during active secretion, cell growth, and normal
turnover in eukaryotic cells. Understanding the mechan-
ism of ER protein quality control, specifically of how the
cell recognizes and discriminates misfolded glycoproteins
remains to be one of the central issues in cell biology.
Conclusions
We have demonstrated that ricin A-chain and a model mis-
folded protein, BACE457 carrying mutations that sig-
nificantly decreased their hydrophobicity, are poorly
recognized by EDEM1 and EDEM2 in contrast to their
wild-type counterparts. Moreover, degradation of mutated
BACE457 with decreased hydrophobicity is significantly re-
duced. The data presented in this paper contribute to the
general understanding of the mechanism of recognition of
misfolded proteins in the ER and the role of EDEM1 and
EDEM2 chaperone proteins in this process.
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Materials
Ricin B-chain was obtained from Vector Labs (Burlingame,
CA), HEPES, α-lactose monohydrate, trypsin, pronase,
bafilomycin A1, pepstatin A and CA074 methyl ester
came from Sigma-Aldrich (St. Louis, MO). [3H]Leucine
was purchased from GE Healthcare (Princeton, NJ),
Na2
35SO4 and L-[
35S]Methionine came from Hartmann
Analytic (Braunschweig, Germany). The mouse monoclo-
nal anti-HA antibodies were obtained from Covance
Research Products (Denver, CO), rabbit anti-BACE from
Merck (Whitehouse Station, NJ), rabbit anti-Ricinus
Communis-Lectin, and mouse anti-α-tubulin came from
Sigma-Aldrich, whereas mouse monoclonal anti-ricin
A-chain were purchased from Serotec (Oxford, UK). The
mouse anti-calnexin were obtained from BD Biosciences
(Palo Alto, CA), anti-calreticulin from BioSite (San Diego,
CA). The rabbit anti-His antibodies came from Santa Cruz
Biotechnology (Santa Cruz, CA). The secondary anti-rabbit
HRP and anti-mouse HRP antibodies, were obtained
from Sigma-Aldrich, whereas anti-rabbit Alexa555 and
anti-mouse Cy-3 were obtained from Jackson laboratories
(Bar Harbour, MA).
Cell culture
Human Embryonic Kidney 293 (HEK293) cells were
grown under 5% CO2 in DMEM (Sigma-Aldrich) sup-
plemented with 10% fetal bovine serum (FBS), 25 U/ml
penicillin, and 25 μg/ml streptomycin (all from Sigma-
Aldrich) in a 37°C incubator.
Cloning, mutagenesis, cDNA constructs and transfections
The ricin A-chain mutants with decreased hydrophobi-
city (RTADHF) and increased hydrophobicity (RTAIHF)
were obtained by site-directed mutagenesis. The following
primers were used: for RTADHF 5’-GTGTGTACGATTC
GAGTATAAATATCCCTATCAATTCGCTCATGGTGT
ATAG- 3’ and 5’-CTATACACCATGAGCGAATTGAT
AGGGATATTTATACTCGAATCGTACCAC-3’ and for
RTAIHF 5’-GTGTGTACGATGTGGTTATATTAATCCCT
ATCATAGTACTCATGGTGTATAG-3’and 5’- CTATAC
ACCATGAGTACTATGATAGGGATTAATATAACCAC
ATCGTACACAC- 3’ The ricin A-chain sulf-1 cDNA
[62] or ricin A-chain fused to 6XHis [23] were used as
templates and the reactions were performed by the stand-
ard procedure [63]. BACE457 with decreased hydro-
phobicity (BACE457DHF) was obtained by site direct
mutagenesis using primers: 5’-GATGAGTCAACCGG
CATG ACCGGAGCCTATGGCATGGCTGCCATCTG
CGCCGGCTTCATGGGGCCACTCTGC-3’and 5’-GC
AGAGTGGCCCCATGAAGCCGGCGCAGATGGCAG
CCATGCCATAGG CTCCGGTCATGCCGGTTGACT
CATC-3’. BACE457 cDNA (a kind gift from Dr. Paolo
Paganetti, Novartis Pharma AG, Basel, Switzerland) [10]was used as a template. Dr. Paolo Paganetti provided also
cDNA encoding soluble form of BACE457 – BACE457Δ.
cDNA encoding the mouse EDEM1 fused to an
hemagglutinin (HA) tag in the pCMV-SPORT2 vector
was a kind gift from Prof. Kazuhiro Nagata and Prof.
Nobuko Hosokawa (Institute for Frontier Medical Sci-
ences, Kyoto University, Japan). For details of the clon-
ing refer to [8]. cDNA encoding the mouse EDEM2
fused to an hemagglutinin (HA) tag in the pRK7 vector
was a generous gift from Prof. Maurizio Molinari (Insti-
tute for Research in Biomedicine, Basel, Switzerland).
For details of the cloning refer to [12].
HEK293 cells were transiently transfected with FuGENE™
transfection reagent (Roche Diagnostics, Basel, Switzerland)
according to the manufacturer’s procedure or TurboFect
(Life Technologies, Carlsbad, CA).Purification of ricin A-chain proteins and reconstitution
with ricin B-chain
RTA His-tag, modified RTADHF His-tag and RTAIHF
His-tag were expressed in E. coli Rosetta cells (Merck)
and purified using Ni-NTA agarose beads (Qiagen,
Germantown, MD) according to the manufacturer’s
manual. The eluate was finally dialysed overnight in PBS.
Ricin A-chain sulf-1 and modified RTAIHF and RTADHF
sulf-1 fused to maltose binding protein (MBP) were ap-
plied to a column with amylose resin and purified as pre-
viously described [22]. Free wild-type RTA, RTADHF or
RTAIHF were cleaved off with factor Xa (New England
Biolabs, Ipswich, MA). For further purification, wild-type
RTA, RTADHF or RTAIHF proteins were applied on a
MonoS column (GE Healthcare) and purified using GE
Pharmacia Acta Purifier (GE Healthcare). 25 mM phos-
phate buffer, pH 6.5 was used as the column equilibrating
buffer and the wash buffer, proteins were eluted with
0–500 mM NaCl gradient, and the fractions containing
ricin A-chain were identified by Coomassie-stained SDS/
PAGE. Purified wild-type RTA, RTADHF or RTAIHF were
mixed with the ricin B-chain and dialyzed extensively
against PBS to remove reducing agents.Protease digestion assays
500 ng of RTA, RTADHF or RTAIHF were incubated with
increasing concentrations of trypsin (0–100 μg/ml) in
NaCl/Pi (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4, pH 7.4) at 37°C for 15 min and then visu-
alized by SDS/PAGE and Coomassie Blue staining. Pronase
digestion was performed at 40°C for 20 min in a buffer con-
taining 0.1 M Tris–HCl, pH 6.5 and 0.5% SDS with in-
creasing concentrations of the protease (0–1.5 μg/ml),
inactivation of the protease was done at 80°C for 5 min.
Proteins were visualized by SDS/PAGE and Coomassie
Blue staining. Denatured forms of RTA were prepared by
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The interchain disulfide bond stability
100 ng reassociated wild-type RTA:RTB, RTADHF:RTB or
RTAIHF:RTB were incubated with increasing concentra-
tions (0.1-10 mM) of dithiothreitol (DTT) at 37°C for
30 min. The reaction was quenched with iodoacetamide
(final concentration 20 mM) at 37°C for 10 min and
then visualized by SDS/PAGE and Coomassie Blue stain-
ing. Denatured forms of ricin were prepared by incuba-
tion of RTA at 85°C for 30 min in 25 mM phosphate
buffer, pH 6.5.
Circular dichroism
Far-UV CD was measured on Jasco J-815 spectrapolari-
meter (Jasco, Tokyo, Japan). Experiments were performed
in 25 mM phosphate buffer, pH 6.5 using a 1-mm-path
length cuvette. The concentration of the protein solutions
were 30 μg/ml. Spectra recorded from 190 to 240 nm with
1-nm step size were averaged from three accumulations
and were corrected against the buffer.
Measurements of protein synthesis
HEK293 cells were washed in leucine free Hepes-buffered
medium and incubated with the same type of medium
with different concentrations of wild-type or mutant ricin
DHF or IHF for 3 hours. The cells were then incubated in
leucine free medium supplemented with 1 μCi/ml [3H]
leucine for 20 minutes at 37°C. Cells were extracted with
5% trichloroacetic acid (TCA) for 20 minutes, followed by
a wash (5 minutes) in 5% TCA and subsequently dissolved
in 0.1 M KOH. The cell-associated radioactivity was mea-
sured. The results are expressed in percent of [3H]leucine
incorporated in cells incubated without toxin. Deviations
between duplicates did not vary by more than 10%.
Measurements of binding and degradation of wild-type
ricin, IHF ricin and DHF ricin
Cell surface binding of wild-type ricin, IHF ricin and
DHF ricin was measured after 30 min incubation with
ricin (~100 ng/ml) at 0°C in Hepes medium. After incuba-
tion, cells were washed four times with ice-cold Hepes-
buffered medium. For the wild-type ricin, IHF ricin and
DHF ricin visualization, Western blot with anti-RTA anti-
bodies was employed. Stability of all types of ricin was
verified in a separate control experiment after 30 min in-
cubation on ice. Proteins were visualized by SDS/PAGE
and Coomassie Blue staining. For degradation measure-
ment, cells were treated either with bafilomycin A1, pep-
statin A, CA074 methyl ester, or a combination of pepstatin
A and CA074 methyl ester, for 30 minutes, and then incu-
bated with wild-type ricin, IHF ricin or DHF ricin for
3 hours. To determine the total amount of ricin remainingin the cells after degradation, Western blot with anti-
RTA antibodies was performed. Concentrations of in-
hibitors are indicated in the figure legends (Figure 4
and see Additional file 3).
Sulfation of wild-type ricin sulf-1 and mutants with
increased or decreased hydrophobicity
HEK293 cells were incubated with approximately 500 ng/ml
of wild-type, DHF ricin or IHF ricin sulf-1 in Hepes medium
for 3 hours at 37°C. For the sulfated ricin analysis, cells were
incubated with 0.2 mCi/ml Na2
35SO4 in DMEM without
sulfate for 3 hours before toxin was added, and the incuba-
tion was continued for the next 3 hours at 37°C. Cells were
then incubated twice (5 min) in a 0.1 M lactose solution at
37°C, to remove surface bound toxin, then washed once
with cold PBS, and lysed (lysis buffer: 0.1 M NaCl, 10 mM
Na2HPO4, 1 mM EDTA, 1% Triton X-100, pH 7.4) in the
presence of a protease inhibitor mixture (Roche Diagnos-
tics). Wild-type ricin, IHF ricin or DHF ricin were immuno-
precipitated from the fractions with rabbit anti-ricin
antibodies and immobilized on protein A-Sepharose
CL-4B (GE Healthcare). Finally, the beads were washed
with cold PBS supplemented with 0.35% Triton X-100,
and the adsorbed material was analyzed by SDS-PAGE
(12%) under non reducing conditions. For the detection
of 35SO4
2−-labeled ricin, dried membranes were exposed
to Kodak BioMax MR film (Kodak, Rochester, NY) at
room temperature. The radioactivity in the cell lysates was
measured to detect possible differences in the total amount
of isotope incorporated under different conditions. For
total ricin analysis in the cell, Western blot analysis
with anti-RTA antibodies was performed. Holotoxin was
detected by chemiluminescence reagent SuperSignal
WestPico Chemiluminescent Substrate (Thermo Scientific,
Waltham, MA). Signal intensities of the bands were quanti-
fied using ImageQuant 5.0 software (GE Healthcare).
Permeabilisation of cells
HEK293 cells were washed once with PBS and incubated
with increasing concentrations of digitonin (0–100 μg/
ml) for 30 min as previously described [22]. After collec-
tion of cytosolic fraction, the cells were lysed as de-
scribed above. The supernatant (containing cytosolic
fraction) and lysates (obtained from the remaining mem-
brane fraction) were centrifuged to remove cell debris
and nuclei for 10 min at 10’000 g. Western blots with anti-
calnexin, anti-calreticulin or anti-BACE antibodies and ap-
propriate secondary antibodies were performed. Proteins
were detected by chemiluminescence reagent SuperSignal
WestPico Chemiluminescent Substrate (Thermo Scientific).
Immunofluorescence microscopy
HEK293 cells transfected with cDNA encoding BACE457,
BACE457DHF or BACE457Δ were grown on coverslips.
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60 μg/ml of digitonin (30 min), washed once with PBS,
and fixed in 3% paraformaldehyde (PFA, Sigma-Aldrich).
Cells were then permeabilised in 0.1% Triton X-100 and
blocked in 5% FCS before labelling with rabbit anti-BACE
together with mouse anti-calnexin and treated with the
appropriate secondary antibodies. The cells were mounted
in Mowiol (Life Technologies) and examined with a Leica
DMI4000B automated inverted microscope.
His-tag pull-down assay
HEK293 cells (1×105/plate) were seeded in 6 cm plates
and transfected with either EDEM1-HA, EDEM2-HA
cDNA or a control vector. Three days post transfection
cells were lysed (lysis buffer: 50 mM Hepes, pH 7.5;
150 mM NaCl; 10% glycerol and 1% Triton X-100) in
the presence of a protease inhibitor mixture (Roche
Diagnostics) and sonicated (5’, 20% output). His-tag fu-
sion proteins: wild-type RTA or mutant RTAIHF, RTADHF
(0.5 μg) were incubated at 37°C for 2 h with lysates from
cells transfected with the indicated constructs and then
incubated with Ni-NTA agarose beads (Qiagen). Beads
were washed three times with lysis buffer supplemented
with 30 mM imidazole and resuspended into a SDS-
PAGE sample buffer. Amounts of toxin-bound EDEM1-
HA or EDEM2-HA were detected after Western blot
with anti-HA antibodies. Signal intensities of the bands
were quantified using ImageQuant 5.0 software (GE Health-
care). Membranes were re-probed with anti-RTA antibodies
to confirm equal amounts of RTA-His, RTADHF-His and
RTAIHF-His used in the experiments.
Metabolic labeling of BACE457 and immunoprecipitation
HEK293 cells (1×105/plate) were seeded in 6 cm plates and
transfected with either BACE457 cDNA or BACE457DHF
cDNA. Three days post transfection cells were starved for
30 min in methionine free MEM medium (Sigma-Aldrich),
pulsed for 10 min with 150 μCi [35S]methionine and chased
for 0, 1, 1.5, 2, 4, 6 hours in complete medium supple-
mented with 5 mM methionine. Then cells were lysed in
Hepes buffered saline (HBS), pH 6.8 containing 2% CHAPS
and a protease inhibitor mixture (Roche Diagnostics). Cell
lysates were prepared by centrifugation at 10,000 g, 10 min
to remove cell debris and nuclei. For immunoprecipitation
of BACE457 or BACE457DHF, lysates were incubated
4 hours at 4°C with protein A-Sepharose CL-4B (GE
Healthcare) precoated with anti-BACE antibodies. Finally,
the beads were washed three times with cold HBS buffer
supplemented with 0.5% CHAPS and 0.1% Tween 20, and
the adsorbed material was analyzed by SDS-PAGE (12%)
under reducing conditions. Densitometric quantification
of BACE457 bands was performed using ImageQuant 5.0
software (GE Healthcare). Percentage of degradation was
determined in at least four independent experiments.Softwares and bioinformatic servers used for protein
characterization
ProtScale [64] was used for generating hydrophobicity
plots with Kyte-Doolittle [65] hydrophobicity scale. Top-
ology prediction of BACE457 and BACE457DHF were pre-
pared by TMHMM Server v. 2.0 [66]. Predicted models of
proteins were prepared by Geno3D server [39]. Proteins
were visualized in the PyMOL Molecular Graphics Sys-
tem, Version 1.3. Schrödinger, LLC [67].
Statistics
All experiments were performed independently at least
three times. Values of 3 or more parallels were given as
a mean ± standard deviation (s.d.). A P value of 0.05 or
less was considered to be statistically significant and de-
termined by the Student’s t-test or ANOVA tests.
Additional files
Additional file 1: Characteristics of RTADHF and RTAIHF.
Additional file 2: Stability of RTADHF and RTAIHF.
Additional file 3: DHF ricin and IHF ricin show increased
degradation in low pH vesicles.
Additional file 4: BACE457 and BACE457DHF luminal parts predicted
ribbon models.
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